February 27, 2015. This is a very brief summary of the concerns of coalition members. The purpose of federal regulations is to protect the U.S. public from harm by implementing reasonable safeguards.
Read More »On Health Policy
Letter to Congresswoman Rosa DeLauro Supporting “Helping Effective Antibiotics to Last” (HEAL) Act
February 12, 2015. The Centers for Disease Control and Prevention (CDC) points out that two major actions are urgently needed to address the threat posed by antibiotic resistance are: 1) stop the misuse of existing antibiotics, and 2) develop effective new antibiotics. HEAL is the first bill to focus on both these necessary actions.
Read More »Statement of Dr. Zuckerman on FDA Commissioner Hamburg’s Resignation
February 5, 2015. The 21st Century Cures proposed legislation represents a frightening assault on the agency and the safety of medical products, and the FDA will need a very strong leader to protect its public health mission.
Read More »NCHR Testimony Before the FDA on “Framework for Regulatory Oversight of Laboratory Developed Tests”
January 8, 2015. Our Center has frequently urged the FDA to improve their oversight of medical devices. Despite past criticisms, we believe it is essential that FDA have the authority to regulate laboratory-developed tests in order to stimulate even better science, and help ensure that patients receive the full benefit of our growing scientific knowledge.
Read More »Letters to Congressional Leadership Supporting the Medical Device Excise Tax
January 9, 2015. This is a sample of the letters that were sent to key Democrats and Republicans in the House and Senate in January 2015.
Read More »